| # | Drug | Count |
|---|---|---|
| 0 | LACOSAMIDE | 14 |
| 1 | LEVETIRACETAM | 14 |
| 2 | LEVETIRACETAM IN SODIUM CHLORIDE | 14 |
| 3 | LEVETIRACETAM INJECTION | 14 |
| 4 | LEVETIRACETAM ORAL | 14 |
| 5 | DROSPIRENONE AND ETHINYL ESTRADIOL | 7 |
| 6 | BRIVARACETAM | 4 |
| 7 | BRIVARACETAM INJECTION | 4 |
| 8 | IBUPROFEN | 4 |
| 9 | OXYCODONE AND ACETAMINOPHEN | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 1 | CLINDAMYCIN PHOSPHATE | 3 | 0.0005 |
| 2 | BRIVARACETAM | 4 | 0.0004 |
| 3 | LACOSAMIDE | 14 | 0.0004 |
| 4 | LEVETIRACETAM ORAL | 14 | 0.0002 |
| 5 | LEVETIRACETAM INJECTION | 14 | 0.0002 |
| 6 | DOXYCLYCLINE HYCLATE | 3 | 0.0002 |
| 7 | OXYCODONE AND ACETAMINOPHEN | 4 | 0.0002 |
| 8 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 2 | 0.0002 |
| 9 | DROSPIRENONE AND ETHINYL ESTRADIOL | 7 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 1 | Estrogen [EPC] | 3 |
| 2 | Opioid Agonist [EPC] | 3 |
| 3 | Progestin [EPC] | 3 |
| 4 | Tetracycline-class Drug [EPC] | 3 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 2 |
| 6 | Benzodiazepine [EPC] | 2 |
| 7 | Vitamin C [EPC] | 2 |
| 8 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1 |
| 9 | Atypical Antipsychotic [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 1 | Tetracycline-class Drug [EPC] | 3 | 0.0000 |
| 2 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Estrogen [EPC] | 3 | 0.0000 |
| 4 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |
| 5 | Opioid Agonist [EPC] | 3 | 0.0000 |
| 6 | Progestin [EPC] | 3 | 0.0000 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Calcium [EPC] | 1 | 0.0000 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 2 | 0.0000 |